...
首页> 外文期刊>The West Indian medical journal. >Antibacterial resistance and trend of urinary tract pathogens to commonly used antibiotics in Kashmir Valley.
【24h】

Antibacterial resistance and trend of urinary tract pathogens to commonly used antibiotics in Kashmir Valley.

机译:克什米尔山谷的细菌耐药性和尿路病原体对常用抗生素的趋势。

获取原文
获取原文并翻译 | 示例
           

摘要

Increase in resistance pattern of urinary tract pathogens to conventional antimicrobial agents used for urinary tract infections (UTIs) is gaining the attention of many microbiologists worldwide in respect to treatment of UTIs. The aim of the present study was to obtain data on resistance patterns of pathogens responsible for UTIs to currently used antimicrobial agents in Sher-I-Kashmir Institute of Medical Sciences (tertiary healthcare hospital). A total of 2842 samples were collected from both outpatient and inpatient departments. The majority of samples in this study were midstream urine specimens, others included catheterized urine samples. Standard parameters were followed for isolation and identification of clinical isolates and further antimicrobial susceptibility test was done by Kirby Bauer disk diffusion method. Out of 2842 samples, 1980 (67%) were culture positive. Escherichia coli (E coli) was the most prevalent isolate (OP 63%, IP 45.5%) followed by Klebsiella pneumonia (K pneumonia) as the second commonest UTI-causing agent (OP 15.9%, IP 21.7%). High percentage of isolates showed resistance to sulfa drugs such as cotrimoxazole. First generation cephalosporins were ineffective, while aminoglycosides and third generation cephalosporins were effective against E coli, K pneumoniae, Pseudomonas aeruginosa (P aeruginosa), Enterococcus faecalis and Staphyococcus aureus (Staph aureus). Furthermore, this study noticed that glycopeptide drugs such as vancomycin are highly effective against E faecalis and Staph aureus UTIs. This study reveals the increased trend in resistance pattern of uropathogens in the valley region. These data may aid health professionals in choosing the appropriate treatment for patients with UTI in the region and hopefully will prevent the misuse of antibiotics.
机译:泌尿道病原体对用于泌尿道感染(UTI)的常规抗菌剂的耐药性模式的提高,在治疗UTI方面引起了全世界许多微生物学家的关注。本研究的目的是获得有关Sher-I-克什米尔医学科学研究所(三级医疗医院)中负责UTI的病原体对当前使用的抗菌剂的耐药模式的数据。从门诊和住院部门总共收集了2842个样本。这项研究中的大多数样本是中游尿液样本,其他样本包括导管尿液样本。遵循标准参数对临床分离物进行分离和鉴定,并通过Kirby Bauer纸片扩散法进行进一步的药敏试验。在2842个样本中,1980年(67%)的培养阳性。大肠杆菌(E.coli)是最常见的分离株(OP 63%,IP 45.5%),其次是第二种最常见的UTI致病菌(OP 15.9%,IP 21.7%)。高百分比的分离株显示出对磺胺类药物(例如曲美唑)的抗药性。第一代头孢菌素无效,而氨基糖苷类和第三代头孢菌素对大肠杆菌,肺炎克雷伯菌,铜绿假单胞菌(铜绿假单胞菌),粪肠球菌和金黄色葡萄球菌(金黄色葡萄球菌)有效。此外,这项研究还注意到诸如万古霉素之类的糖肽药物对屎肠球菌和金黄色葡萄球菌的尿路感染都非常有效。这项研究揭示了在山谷地区的尿路致病菌的抵抗模式的增加趋势。这些数据可以帮助卫生专业人员为该地区的UTI患者选择合适的治疗方法,并有望防止滥用抗生素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号